WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Peptide synthesis reagents and method of use    
United States Patent4507230   
Link to this pagehttp://www.wikipatents.com/4507230.html
Inventor(s)Tam; James P. (New York, NY); Heath, Jr.; William F. (New York, NY); Merrifield; Robert B. (Cresskill, NJ)
AbstractA method of releasing a functional group present in an amino acid or amino acyl residue from a resin or protecting residue which is bonded to the functional group by a linkage having proton affinity, which comprises: reacting the functional group bonded to the organic residue, with a mixture of HF and a base for a time and under conditions effective to produce the release; wherein the amounts of HF and base in the mixture are adjusted so that said release occurs substantially by an S.sub.N 2 mechanism.



 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History
Inventor     Tam; James P. (New York, NY); Heath, Jr.; William F. (New York, NY); Merrifield; Robert B. (Cresskill, NJ)
Owner/Assignee     Research Corporation (New York, NY)
Patent assignment
All assignments
Publication Date     March 26, 1985
Application Number     06/377,443
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     May 12, 1982
US Classification     530/334 525/54.11 530/337 930/10 930/20 930/80 930/DIG.631 930/DIG.641
Int'l Classification     C07C 103/52 C08L 089/00
Examiner     Phillips; Delbert R.
Assistant Examiner     Moezie; F.
Attorney/Law Firm     Scully, Scott, Murphy & Presser
Address
Parent Case    
Priority Data    
USPTO Field of Search     424/177 260/112.5 R 525/54.11
Patent Tags     peptide synthesis reagents
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
4062815
Hughes
525/54.11
Dec,1977

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


What is claimed as new and intended to be protected by Letters Patent of the United States is:

1. In a method of synthesizing peptides by the solid phase methodology, wherein the growing peptide chain is covalently attached by a functional group through a linkage having proton affinity, to the organic residue of a resin, the improvement wherein said peptide is detached from said resin using a mixture of HF and a base selected from the group consisting of di-C.sub.1 -C.sub.1O -alkyl sulfides and alkyl phenyl sulfides, wherein the amounts of HF and base in said mixture are adjusted so that said detachment occurs predominantly by an S.sub.N 2 mechanism, said HF being present in said mixture in an amount between 0.1 and 60% by volume.

2. The method of claim 1 wherein said base also serves as diluent in said mixture.

3. The method of claim 1 wherein said base has a pKa of between -2 and -11.

4. The method of claim 1 wherein said dialkylsulfide is dimethyl sulfide.

5. The method of claim 1 wherein said linkage having proton affinity is an ester, ether or carbamate linkage.

6. The method of claim 1 wherein said HF is present in said mixture in an amount sufficient to protonate at least 1% of said linkage.

7. The method of claim 1 wherein said HF is present in said mixture in an amount such that detectable amounts of unprotonated base remain in the solution.

8. The method of claim 7 wherein said base is protonated no more than 99%.

9. The method of claim 1 wherein the mixture further comprises about 1 to about 20 percent by volume of scavengers for carbocations including phenols, indoles, ethers, thioethers, thiophenols and sulfides.

10. The method of claim 1 wherein said mixture also contains 1-50% by volume of a compound capable of swelling a polymeric resin.

11. The method of claim 1 wherein said functional group is --COOH, --NH.sub.2, --SH, --OH, >NH, --S-- or ##STR9##

12. The method of claim 1 wherein said mixture also comprises a polar solvent.

13. The method of claim 1 wherein the organic residue of said resin is a benzyl residue.

14. The method of claim 1 wherein said resin is a polystyrene resin.

15. The method of claim 1 wherein said mixture is a binary mixture comprising HF and dimethylsulfide, wherein the HF is present in said mixture in 0.1-60% by volume.

16. The method of claim 1 wherein said mixture also contains between 1 and 10% by volume of a C.sub.1 -C.sub.10 alkyl thiol or any aryl thiol.

17. The method of claim 14 wherein said mixture contains 1-20% by volume of a phenol.

18. The method of claim 1 which, after said reaction of said mixture with said peptide, comprises the additional step of reacting said peptide with HF at a concentration of greater than 60% by volume.

19. In the method of claim 1 wherein said peptide is selected from the group consisting of C-terminal-pentapeptide amide of gastrin, cecropin A (1-33), glucagon, Tyr.sup.22 -glucagon, and human gastrin (1-17).
 Description Submit all comments and votes
 


1. Field of the Invention

The present invention relates to improved deprotection reagents used in peptide synthesis, especially in automated solid-phase peptide synthesis.

2. Brief Description of the Prior Art

The synthesis of peptides is generally carried out through the condensation of the carboxyl group of an amino acid, and the amino group of another amino acid, to form a peptide bond. A sequence can be constructed by repeating the condensation of individual amino acid residues in stepwise elongation, or, in some cases, by condensation between two preformed peptide fragments (fragment condensation). In such condensations, the amino and carboxy groups that are not to participate in the reaction must be blocked with protecting groups which should be readily introduced, be stable to the condensation reactions and be removed selectively from the completed peptide. If a peptide involves amino acids with side chains that may react during condensation, the problem of protection becomes increasingly difficult. A great range of reactive groups and side chains--amino, carboxy, thiol, hydroxy, and so on--must be adequately blocked. Their blocking must be stable to unmasking of the .alpha.-amino or .alpha.-carboxy block for stepwise condensation, and must be readily removed at the final stage, leaving the completed peptide moiety intact.

A successful synthesis for a large peptide by a linear strategy must achieve nearly quantitative recoveries for each chemical step. This demanding requirement has been met by solid-phase peptide synthesis, pioneered by R. B. Merrifield. In such a synthesis, the peptide chain is normally attached by a benzyl-type carboxy-protective group to a polystyrene resin. A first amino acid is attached to the resin by a benzyl linkage, deblocked at its amino side, and coupled with a second amino acid, carrying a protected .alpha.-amino group. The resulting protected dipeptide ester is deblocked with trifluoroacetic acid, converted into the free amine with base, and coupled to a second N-protected amino acid. After many repetitions of these steps, the complete peptide is cleaved from the resin with acid treatment. By using the insoluble resin support it is possible to isolate the product of each coupling reaction simply by filtering the resin and washing it free of by-products and excess starting materials. In fact, the synthetic processes are so simplified and the time required for one cycle is so shortened that in recent years it has become quite common to use automated peptide synthesizers. (See for example Barany, G. and Merrifield, R. B., "The Peptides, Vol. 2": Academic Press, Inc., New York, 1979, pp. 1-284; or Kemp-Vellaccio, "Organic Chemistry", pp. 1030-1032 (1980)).

Normally, the synthesis of peptides, either in solution or in solid phase, culminates in a final strong acid step in which all the protecting groups and the polymeric support are removed. For this purpose, acids with strong protonating properties such as hydrogen fluoride (Lenard, J. et al, Journal of the American Chemical Society, 89:181-182 (1967)), hydrogen bromide (Merrifield, R. B., Biochemistry, Vol. 3, 1385-1390 (1964)) or sulfonic acids (Yajima, H. et al, Chem. Pharm. Bull., 22:1087-1094 (1974)) have been used. However, several serious side reactions are known to be associated with these strong acids. For example, alkylation of nucleophilic side chains of tyrosine, methionine, tryptophan and cysteine, by carbocations generated from the alcohol component of the protecting groups (benzyl, tertiary butyl, and the like), is normally observed (See for example, Martinez, J. et al, Synthesis: 1981, 333-356). Another problem is dehydration of the protonated side chain carboxylic acid of aspartic and glutamic acids, followed by acylation reactions of the resulting acylium ions (Feinberg, R. S. and Merrifield, R. B., J. Amer. Chem. Soc. 97:3485-3494 (1975)). For example, the design of phenolic OH tyrosine protecting groups has been a challenging problem for peptide synthesis. The difficulty has been the tendency of the alkylation of the phenolic ring of tyrosine during strong acid removal of the O-alkyl-tyrosine protecting group. Among the commonly used protecting groups for tyrosine are R.dbd.benzyl, 2,6-dichlorobenzyl, 2-bromobenzoxycarbonyl and cyclohexyl. Of these, O-benzyl tyrosine gives the most alkylated product during strong acid treatment. This is shown in Scheme I: ##STR1##

It has long been recognized that the 3-alkylated product (2) is the result of a cleavage mechanism in which the generated alkylcarbocation leads to the C-alkylation of the nucleophilic phenyl ring at the 3-position.

Sequential acid treatment during peptide synthesis, also often leads to electrophilic alkylation of unprotected tryptophan residues. This alkylation has been recognized to be more serious than the final strong acid cleavage step (Chino N. et al, Peptide Chemistry 1977 Protein Research Foundation, pp 27-32, Osaka, Japan). For example, the acidolytic removal of N.sup..alpha. -tertbutoxycarbonyl group by trifluoroacetic acid results in about 30% of t-butylated tryptophan side products. Although the seriousness of the alkylation can be reduced in the presence of appropriate scavengers during the acid treatment, it is best to prevent the alkylation side reaction by protecting the indole moiety against electrophiles during the synthesis. This has been achieved by using N.sup.i -formyl protecting groups, which effectively decrease the electrophilicity of the indole tryptophan ring and prevent alkylation side reactions. N.sup.i -formyl tryptophan is stable to strong acid, including HF and sulfonic acids, but is usually removed after the strong acid deprotection of side chain protecting groups and removal from the resin support, by nucleophiles or aqueous bases, thus requiring an additional step, and resulting in further side reactions.

Still another amino acid residue which is the subject of problems during peptide synthesis is methionine. The incorporation of unprotected methionine into a synthesis faces side reactions of the thioether side chain being S-alkylated to sulfonium, or oxidized to sulfoxide groups. Since this side reaction is often left to be corrected during the purification step, not all S-alkylation is reversible (see for example Hofmann, K., Journal of the American Chemical Society 87: 631 (1965)). Alternatively, the use of methionine sulfoxide (met (O)) in the synthesis avoids the S-alkylation side reaction due to reduced nucleophilicity of the thioether side chain. However, both strategies result in the similar uncertainty of converting met(O) to met at the purification step. In general, methionine sulfoxide is stable to HF cleavage conditions and requires subsequent thiolytic reductions to methionine, after the removal of all the protecting groups. This again necessitates an extra step, and is, in addition, always slow, and often accompanied by side reactions (Houghton, R. A. Analytical Biochemistry 98: 36 (1979)).

The art has, for a long time, sought final step deprotection conditions which will overcome one or more, or possibly all, of the aforementioned problems. Thus, several studies on the effect of nucleophilic sulfur scavenger systems during acidolytic deprotection have appeared in the literature on peptide chemistry. In 1977 it was observed by Brady et al (Journal of Organic Chemistry 42: 143 (1977)) that dimethyl sulfide enhanced the rate of cleavage of the benzoxycarbonyl group ("Z group") in trifluoroacetic acid. Kiso et al (Chem Pharm Bull 28: 673 (1980)) found that the Z group could be completely removed by trifluoroacetic acid at room temperature when thioanisole, instead of anisole, was employed as a cation scavenger. These authors also stated that removal of the benzyl group (Bzl) from Tyr(Bzl), Thr(Bzl) and Ser(Bzl) by trifluoroacetic acid was accelerated by various sulfur compounds, but to a different extent. Yajima et al (Chem Pharm Bull 28: 1214-1218 (1980)) developed a system of using trifluoroacetic acid-thioanisole-m-cresol for the removal of benzyloxycarbonyl groups from N-.omega.-amino group of lysine. Kiso et al (Chem Pharm Bull 26: 2563-2564 (1978)) described the use of thioanisole as a scavenger for the deprotection of O-protected tyrosine under acidic conditions. Mixtures of anisole and HF were also tested in their work and the extent of rearrangement of tyrosine protected with 2,6-dichlorobenzyl, or tyrosine protected with benzyl, were examined. Finally, Node et al have suggested the use of mixtures of dimethylsulfide and aluminum trichloride for dealkylation of esters, such as aliphatic or aromatic carboxylic acid esters.

All of the aforementioned research, however, is based on the use of acids such as HF or trifluoroacetic (TFA) in high concentrations (>60-65%). Under these conditions carbocations are generated due to an S.sub.N 1 type of mechanism, and scavengers are therefore necessary to remove these carbocations. In some instances it has been proven useful to work with an acid such as HBr which operates partly on a S.sub.N 2 mechanism, and may thus prevent side reactions (Homer, R. B. et al Proc. Chem. Soc., 1963, 367). Hydrogen fluoride, however, which is nonoxidizing and much more volatile, is usually much preferred over HBr. No successful method using HF, which prevents the serious side reactions described previously, has yet been designed by the art.

A need therefore continues to exist for a deprotection reagent for peptide synthesis, especially for solid phase peptide synthesis, which will not suffer from the severe side reactions, rearrangements, and the like which characterize the reagents of the prior art, and which may also serve as a deprotection reagent for a variety of amino acid residues.

SUMMARY OF THE INVENTION

It is therefore an object of the invention to provide new reagents for acidolytic deprotection of amino acid residues in peptide synthesis.

It is another object of the invention to provide a method for the synthesis of peptides.

These and other objects of the invention as will hereinafter become more readily apparent have been attained by providing:

A method of releasing a functional group present in an amino acid or amino acyl residue from a resin or protecting residue which is bonded to said functional group by a linkage having proton affinity, which comprises:

reacting said functional group bonded to said resin or protecting residue with a mixture of HF and a base, for a time and under conditions effective to produce said release;

wherein the amounts of HF and base in said mixture are adjusted so as to cause said release to occur substantially by an S.sub.N 2 mechanism.

Another object of the invention has been attained by providing:

In a method of synthesizing peptides which includes protecting amino acid or amino acyl side residues with acid labile protecting groups through a linkage having proton affinity, the improvement wherein said protecting groups are removed with a mixture of HF and a base, wherein the amounts of HF and base in the mixture are adjusted so as to cause the removal of said protecting group to occur substantially by an S.sub.N 2 mechanism.

Yet another object of the invention has been attained by providing:

In a method of synthesizing peptides by the solid-phase methodology, wherein the growing peptide chain is covalently attached by a functional group through a linkage having proton affinity, to the organic residue of an insoluble resin, the improvement wherein said peptide is detached from said resin using a mixture of HF and a base, wherein the amounts of HF and base in said mixture are adjusted so that said detachment occurs substantially by an S.sub.N 2 mechanism.

BRIEF DESCRIPTION OF THE DRAWINGS

A more complete appreciation of the invention and many of the attendant advantages thereof will be readily obtained as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings, wherein:

FIG. 1 demonstrates the composition of a generalized ternary system (HF-solvent-base) in the S.sub.N 1 and S.sub.N 2 cleavages of Tyr(Bzl). The shaded area is of the S.sub.N 2 type. The smooth curve dividing the equilateral triangle is made up of points where transition from S.sub.N 2 to S.sub.N 1 is observed;

FIG. 2 demonstrates the different behavior of weak bases such as sulfides in a ternary system (HF-trifluoroacetic acid-sulfide) as represented by the equilateral triangle diagram. The smooth curves dividing the triangle show the change-over points from S.sub.N 2 to S.sub.N 1 mechanism when a given sulfide is used as base;

FIG. 3 demonstrates the effect of potentiating and deactivating solvents in a ternary system: HF-solvent-dimethylsulfide as represented by the equilateral triangle diagram;

FIG. 4 demonstrates the dependence of the rate of deprotection of Ser(Bzl) on the concentration of HF in dimethylsulfide;

FIG. 5 demonstrates the dependence of deprotection of O-Benzyltyrosine on the concentration of HF in dimethylsulfide, showing both the cleavage yield of O-Benzyltyrosine (--.quadrature.--), the formation of 3-Benzyltyrosine by the alkylation side reaction (--.DELTA.--) and of the benzyldimethylsulfonium ion ( );

FIG. 6 demonstrates the dependence of deprotection of N.sup.i -formyl tryptophan by various concentrations of HF in dimethylsulfide, in the presence of p-thiocresol, maintained at 5% by volume;

FIG. 7 demonstrates the dependence of methionine sulfoxide reduction, on the percent volume of HF in dimethyl sulfide;

FIG. 8 demonstrates the high pressure liquid chromatographic analysis of crude pentagastrin amide on a reverse phase .mu.Bondapak C-18 column (4.times.300 mm), linear gradient of 2 to 98% solution B (H.sub.2 O:CH.sub.3 CN:H.sub.3 PO.sub.4 50:50:0.1, v/v/v) into solution A (H.sub.2 O:CH.sub.3 CN:H.sub.3 PO.sub.4 95:5:0.1, v/v/v), 2 ml/min. Detection at 280 nm, 0.1 absorbance full scale;

FIG. 9A demonstrates the high pressure liquid chromatographic analysis of crude Cecropin A(1-33) on a reverse phase .mu.Bondapak C-18 column (4.times.300 mm), linear gradient of 10 to 50% solution B (H.sub.2 O:CH.sub.3 CN:H.sub.3 PO.sub.4 2:8:0.01, v/v/v) into solution A (H.sub.2 O:CH.sub.3 CN:H.sub.3 PO.sub.4 9:1:0.01, v/v/v), 2 ml/min. Detection at 225 nm, 0.1 absorbance full scale;

FIG. 9B demonstrates the high pressure liquid chromatographic analysis of purified Cecropin A(1-33) on a reverse phase .mu.Bondapak C-18 column (4.times.300 mm). Conditions of the analysis are similar to those in FIG. 9A;

FIG. 10 demonstrates the high pressure liquid chromatographic analysis of crude (Tyr.sup.22) glucagon on a reverse phase .mu.Bondapak C-18 column (4.times.300 mm), linear gradient of 30 to 50% solution B (H.sub.2 O:CH.sub.3 CN:H.sub.3 PO.sub.4 2:8:0.01, v/v/v) into Solution A (H.sub.2 O:CH.sub.3 CN:H.sub.3 PO.sub.4 9:1:0.01, v/v/v), 2 ml/min, Detection at 280 nm, 0.1 absorbance full scale;

FIG. 11 demonstrates the DEAE-Sephacel chromatographic analysis of crude (Tyr.sup.22) glucagon after HF cleavage by the improved method of the invention. Elution with a linear gradient of 0.01M Tris in 6M urea, 0.3N NaCl (Buffer B) to 0.01M Tris in 6M urea (Buffer A). 0.3 ml/mn. Detection by radioactivity (--.DELTA.--) (10.sup.3 cpm) and absorbance at 280 nm (--0--);

FIG. 12 demonstrates the CM-52 chromatographic analysis of crude (Tyr.sup.22) glucagon after HF cleavage by the standard method (HF-p-cresol 9:1, v/v). Elution with a linear gradient of 0.1M ammonium acetate in 6M urea (Buffer B) to 0.01M ammonium acetate in 6M urea (Buffer A). Flow rate 0.3 ml/min, detection by radioactivity (--0--), (10.sup.3 cpm) and absorbance at 280 nm (--.DELTA.--); and

FIG. 13 demonstrates the high pressure liquid chromatographic analysis of purified (Tyr.sup.22) glucagon on a reverse phase .mu.Bondapak column (4.times.300 mm). Conditions similar to those in FIG. 11

DESCRIPTION OF THE PREFERRED EMBODIMENTS

In their search for a reagent which would be useful for carrying out the final step in peptide synthesis, (i.e., the deprotection of all amino acid functional groups which are protected with acid labile protecting groups, and, when working in solid phase, the detachment of the synthetic peptide from the solid phase), the present inventors discovered limiting conditions within which HF could be used substantially without any of the serious side reactions of the prior art, and could be used for an expanded number of deprotections. Although in the prior art it has generally been believed that HF is, in fact, useful as a final step reagent in peptide synthesis, the prior art has had to accept the fact that severe side reactions occur with this reagent. The present inventors, however, have discovered that, under certain controlled circumstances, HF can be used without the side reactions.

The controlled circumstances or limiting conditions for final step reaction, according to the present invention, are those wherein HF is used at much lower concentrations than was previously customary in the prior art. In addition, the reaction is carried out in the presence of a base. The amount of HF is adjusted in the reagent mixture so that it will be sufficient to at least partially protonate the linkage joining the functional group present in the amino acid or amino acyl residue with the residue to be cleaved therefrom, yet insufficient to fully protonate the base present in the mixture.

Without being bound by any particular theory, applicants believe that, under these conditions, the fraction of unprotonated base present in the mixture enters--as a nucleophile--into a bimolecular nucleophilic substitution reaction (S.sub.N 2) with the detachable organic residue involved, (e.g. the protecting group), thereby releasing the amino acid or amino acyl functional group in protonated form. In other words, applicants have found conditions wherein an HF-based, final step reagent is fully capable of utilizing an S.sub.N 2 type of mechanism, instead of the S.sub.N 1 cleavage mechanism seen in the prior art. The first of these two alternatives is schematically shown in Scheme II:

Scheme II (S.sub.N 2 mechanism): ##STR2##

In this scheme, P is an insoluble polymeric resin used in solid phase synthesis. --Q.sub.r1 --CH.sub.2, --Q.sub.r2 --CH.sub.2 -- and --Q.sub.r3 are organic residues which are released from the amino acid functional groups during the reaction. Thus, --Q.sub.r1 --CH.sub.2 -- is attached to the polymeric resin and serves as the bridging group between the polymeric resin and the peptide (in this case a single amino acid, shown for illustration only). Q.sub.r2 --CH.sub.2 -- is an organic residue which is utilized as a protecting group for the amino acid functional group R.sub.1. Q.sub.r3 is a protecting group for the terminal amino group. B is a base. Scheme II shows the probable mechanism by which reactions occur in the present invention. First, protonation occurs at the residue R.sub.1 having proton affinity, and at the carbonyl oxygen of the terminal carboxy group of the amino acid. In a second step, the base attacks the CH.sub.2 carbon of the organic residue, releasing the protonated functional groups, and yielding detached and deprotected amino acid, as well as resin, and protecting groups covalently attached to the base.

In comparison, at high concentrations of hydrogen fluoride, such as those of the prior art, it is believed that the mechanism is as shown in Scheme III.

Scheme III (S.sub.N 1 mechanism): ##STR3##

It is shown in Scheme III that, at high HF concentration, the mechanism proceeds via free carbocations P--Q.sub.r1 --CH.sub.2.sup.+, Q.sub.r2 --CH.sub.2.sup.+ and Q.sub.r3.sup.+. In the prior art, these carbocations have been scavenged with cationic scavengers such as bases. However, in the present invention, the primary function of the base is to serve as the nucleophilic displacement reagent, although it is envisioned that some cationic scavenging would also occur by such base. Because of the nature of the mechanism, and the absence of free cationic intermediates (which would otherwise undergo acylation or alkylation reactions), such side reactions are severely suppressed in the present invention.

In essence, the invention is based on the discovery that a changeover in mechanism from S.sub.N 1 to S.sub.N 2 occurs in going from high HF concentrations to low HF concentrations. Although such change in mechanistic behavior has been observed with other acids (see for example Yates, K. and McClelland, R. A. Journal of the American Chemical Society 89: 2686-2692, 1967), the present inventors were the first ones to recognize the existence of such changeover in HF solutions, and to successfully utilize this changeover in formulating a reagent for final-step reaction in peptide synthesis.

A great variety of functional groups present in amino acids or amino acid residues can be involved in deprotection reactions. In addition, the term "functional group" as used in the present invention and claims also includes the amino acid group utilized to bind the peptide chain to a solid polymeric resin, in the case of solid phase synthesis. Normally, this bridging functional group is a carboxy group. The most common functional groups which are protected during peptide syntheses are those present in the side chains of the amino acids, and include such functional groups as OH (both aromatic and aliphatic); NH.sub.2 ; COOH; nitrogen atoms of imidazole rings, of tryptophan rings, or of arginine; and SH or --S--CH.sub.3. When one includes the resin-bridging amino acid functional group used during solid phase synthesis, the amino acids involved in the method of the present invention thus comprise the aliphatic amino acids, such as glycine, alanine, valine, leucine, and isoleucine; the hydroxy amino acids such as serine and threonine; the dicarboxylic amino acids and amides such as aspartic acid, asparagine, glutamic acid and glutamine; the amino acids having basic functions such as lysine, hydroxylysine, histidine, and arginine; the aromatic amino acids such as phenylalanine, tyrosine, tryptophan, and thyroxine; the sulfur containing amino acids such as cysteine and methionine; and other amino acids such as proline or hydroxyproline. Any other amino acids, natural or non-natural, are of course also included in the present invention. The amino acids may be present by themselves, at the end, or along the chain of a synthetic peptide.

By the term "releasing" as used in the invention and in the claims is meant the splitting or cleavage of the covalent chemical bond which serves to unite the amino acid functional groups to their respective protecting groups or resin-bridging residues. In the process of the present invention, i.e. in the final step of peptide synthesis, the functional groups are freed from whatever protecting group or resin they may have been covalently attached to during the previous process of synthesis.

The terms "resin or protecting residue" as used in the present invention and in the claims are meant to include both the normally used protecting groups, as well as the organic functional groups which link a growing peptide chain to a polymeric resin. In the most general sense, these residues should be able to undergo bimolecular nucleophilic substitution by a base, i.e. they are the electrophilic acceptors in the S.sub.N 2 mechanism. A wide range of protecting residues are used and are well known to the art. They include for example, benzyl, 2-chlorobenzyl, 2,6-dichlorobenzyl, bromobenzyl, carbobenzoxy, methylbenzyl, methoxybenzyl, benzhydryl, substituted carbobenzoxy, and the like. In the case where the residue is a bridging residue between the peptide and a polymeric resin, it has been customary to use the benzyl group in that role, since it is derived from attachment of the first amino acid in the peptide to chloromethylated residues on a polystyrene resin. The invention, however, is not only limited to that particular embodiment. Polyacrylamide, substituted polyethylenes, polyethyleneglycol, phenolic resins, polysaccharides (e.g. Sephadex, cellulose) soluble, non-crosslinked polystyrene, etc. can also be used as resins.

The linkage linking the functional group and the resin or protecting residue is, by the nature of the atoms present therein (O, N or S in most cases) basic, that is, it has proton affinity.

Any bond cleavable by a bimolecular nucleophilic substitution reaction of the base on the protecting or resin residue can be used. Preferably, the bonds are acidolytically labile, and include all those which, in the past, have been deprotected with mixtures containing high concentrations of HF. The most common linkages as used in the invention are ethers or thioethers (R.sup.1 --CH.sub.2 --O (or S) --CH.sub.2 --R.sup.2), esters ##STR4## carbamates ##STR5## benzhydrylamide, sulfenylamine, or sulfonylamides, wherein R.sup.1 is the radical of an amino acid or aminoacyl moiety and R.sup.2 is the radical of a protecting group therefor, or R.sup.2 is a polymeric resin. In the most preferred mode, R.sup.2 is a phenyl or halo-substituted phenyl group which may or may not be attached to a resin.

The bases useful in the present invention are normally weak bases since, given their crucial role as nucleophiles in the reaction, they have to comply with the condition that they not be fully protonated by the HF. The most preferred bases are those having pK.sub.a values ranging between -2 and -11. In addition, the bases should be nucleophilic. Among the preferred bases are sulfur containing bases, such as thiols or sulfides. Among the best are di-C.sub.1 -C.sub.10 -alkylsulfides (linear or cyclic) wherein the alkyls are the same or different, alkyl phenyl sulfides, thiophenols, p-thiocresol, 3,4-dithiotoluene, 1,2-dithioethane, ethanethiol, thioanisole, tetrahydrothiophene and the like. Oxygen bases such as phenol, m-cresol, p-cresol or anisole can also be used. Because of their nucleophilicity, pKa and volatility properties, the di-lower alkyl sulfides are the most preferred and dimethylsulfide is, at the present time, the best of all.

The concentration of HF is to be adjusted according to the proton affinity (strength) of the accompanying base and according to the proton affinity of the linkage between the functional group and the protecting or resin residue, in order to cause the mechanism to be predominantly S.sub.N 2 in character, rather than S.sub.N 1 in character, i.e., fall within the range wherein the linkage is partially protonated and the base is not fully protonated. Given the availability of "indicator systems," see infra and of pKa values for bases and proton affinity values of the linkage functional groups, e.g. ethers, thioethers, carbamates, amides, acyl guanidine, acylimidazole and the like, it is a matter of testing or calculation to define this concentration. The concentration will also depend on the polarity of the solvent mixture, the hydrogen-bonding ability of the cosolvent and the dissociation of HF itself. Therefore, in the more polar solvents the effective HF concentrations may be smaller than in less polar solvents. In general, the concentration of HF is adjusted so that the acidity of the solution, as measured by the Hammett acidity function HO (see for example Hammett, Chemical Reviews 16: 67 (1935); "Physical Organic Chemistry" McGraw-Hill Book Company, New York, N.Y. 1940; as well as Hyman and Garber "The Hammett Acidity Function Ho for Trifluoroacetic Acid Solutions of Sulfuric and Hydrofluoric Acids," Journal of the American Chemical Society, Volume 81, 1847, 1849 (1959), both of which are herein incorporated by reference), is at most within plus or minus one whole logarithmic unit of the pKa of the base. Thus, the acidity of the mixture may be in the range of from -1 to -11. In general terms, the percent by volume of HF in the solution can be between 0.1% and 60%. More particularly, in using lower dialkyl sulfides as the bases and as the diluents, the concentration of HF may range from about 15% to 50%, most preferably 20-40%.

In order for the method of the invention to proceed effectively, the linkage between the functional group and the protecting or resin residue has to be at least partially protonated. By "partially protonated" is meant that at least 1% of the linkage is in the protonated form and 99% is in the unprotonated form. This ratio can be calculated from the proton affinity of the linkage functional group. Also, the base should be sufficiently unprotonated. By the terms "sufficiently unprotonated" is meant that at least 1% should not be protonated and be free to function as a nucleophile.

The release reaction carried out in the final step of peptide synthesis according to the present invention can be performed over a wide range of temperature and time conditions, which conditions are only limited by experimental expediency and can be readily determined by those of ordinary skill in the art without undue experimentation. Normally, the reaction can be carried out at from about -10.degree. C. to room temperature (.about.25.degree. C.), preferably at 0.degree. C. The time can be ascertained by following the yield of free peptide, and is normally within the range of from 5 minutes to 12 hours. The reagent of the present invention is used in molar excess over the molar amount of protected and attached functional groups in the peptide.

The reagent can be used as such (HF plus base, binary systems) or diluted in a solvent, preferably in polar protic solvents such as trifluoroacetic acid, acetic acid, and other protic acids (ternary systems). The reagent can also be used in the presence of additional cationic scavenging compounds such as 1-20% v/v of phenols, indoles, ethers, thioethers, thiophenols, sulfides. Sufficient amounts of resin swelling compounds preferably 1-50%, especially 1-20%, of compounds such as aromatics, chlorinated hydrocarbons, ethers, esters and the like can also be added.

In the present invention the question of whether any given cleavage reaction is occurring under S.sub.N 2 or S.sub.N 1 mechanism conditions, can be readily determined (infra). The reaction can then be done under HF, solvent and base conditions which will fall within the (desired) S.sub.N 2 region.

The change-over point can be readily measured by a number of reactions ("indicator systems"). Some "indicator systems" that show the change of S.sub.N 2 to S.sub.N 1 mechanism are:

(a) Deprotection of Boc-Tyr(Bzl). (See Example 2 and FIG. 5). The S.sub.N 2 reaction in this indicator system is characterized (at 0.degree. C., 1 hour) by a reduction in side product, 3-benzyl-tyrosine, and a corresponding quantitative increase in production of sulfonium salts. The S.sub.N 1 reaction, on the other hand, gives significant amounts of 3-benzyl-tyrosine as side product and, furthermore, it produces little sulfonium salts, but significant amounts of aromatic side products, due to the dimerization or polymerization of the benzylic cation. This pattern is repeatedly seen when such reaction product mixtures are analyzed by reverse phase high performance liquid chromatography.

Any system (binary or ternary or higher) wherein the amount of 3-benzyltyrosine is lower than about 15%, preferably lower than about 5%, and/or wherein the amount of sulfonium salts is higher than about 85%, preferably higher than about 95% in this indicator system, can be considered to be in the S.sub.N 2 region.

(b) Rate of deprotection of Ser(Bzl). The S.sub.N 2 reaction in this indicator system (at 0.degree. C.) is characterized by a slow rate of benzyl protection group removal and a slow change in rate with the addition of HF, while the S.sub.N 1 reaction produces faster rate changes with the addition of HF. The slope change for the rate of reaction by the S.sub.N 2 mechanism is less than 1, while the slope change for the S.sub.N 1 type is greater than +2;

(c) In addition, the S.sub.N 2 type of reaction causes a chemical reduction of Met(O) to Met in the presence of the appropriate sulfide, and deprotects Trp(For) to Trp in the presence of a thiol. Both of these reactions are slow or do not occur significantly in an S.sub.N 1 type of reaction.

Therefore using any of these "indicator systems" (a, b or c) one skilled in the art can determine the changeover for any HF/base system, whether the system is binary or higher.

In binary HF/base mixtures, with phenolic or thiophenolic additives, there are many combinations that will be effective in the present invention, where the cleavage mechanism is largely an S.sub.N 2 type (as long as the sulfide is not totally protonated). For example, in systems with HF-sulfide as the binary mixture, the change-over of mechanism from S.sub.N 2 to S.sub.N 1 with respect to HF concentration (in vol %) is about 55% for dimethylsulfide, and about 65% for thioanisole. However, the addition of phenolic and thiophenolic compounds affects this change-over point. The effect depends on the solvent system. In general, the pKa of the weak base, such as sulfide, and the potentiating or deactivating effect of the added solvent will shift the change-over point. Usually, the weaker the base, the higher the concentration of the HF required for the change-over in mechanism. If thioanisole is further substituted with electron withdrawing groups such as C1, Br, NO.sub.2 etc., the pKa of the sulfide will be lower. Accordingly, the change-over point will be moved towards higher concentrations of HF.

Since the ability of the reagent of the invention to remove protecting groups or resin groups by an S.sub.N 2 mechanism depends on the H.sub.o of the acid system, it is possible either to potentiate or to deactivate the HF by the addition of various solvents. For example, trifluoroacetic acid (TFA) has long been known to potentiate the H.sub.o of HF. The H.sub.o value for 100% HF is -11 and for 50% HF in an inert diluent is -6. 100% TFA has a pKa of -3.3. However, the addition of 0.9% vol % of HF to TFA will bring the H.sub.o of the HF-TFA mixture to -6.0. Thus, when various concentrations of HF in TFA, containing 10% of dimethylsulfide, are used to test the change-over point from an S.sub.N 2 to an S.sub.N 1 reaction according to the tyrosine alkylation indicator system, it is found that the mechanism changes at only about 5% by volume of HF. This is in sharp contrast to the HF-dimethylsulfide binary system where the change-over point is at about 55% by volume.

The variation in the change-over point of a three-component system with changes in the composition can be conveniently represented on an equilateral triangle graph. FIGS. 1-3 illustrate the application of the invention results on a series of equilateral triangle plots. The three illustrated components e.g. solvent, HF and base occupy the apices of the triangle, which represent 100% of each component. Any point along the line opposite to the apex represents 0% of that component. The composition of any point in the system can be represented by the length of a perpendicular to the given side for each component. If the change-over points from S.sub.N 2 to S.sub.N 1 reaction given by the solvent, HF and base system are plotted as in FIG. 1, then a smooth curve can be drawn through these points, dividing the equilateral triangle into two parts. The shaded area represents the compositions of solvent, HF and base that operate through an S.sub.N 2 mechanism, while the clear part represents the compositions where the ternary mixture operates predominately through an S.sub.N 1 mechanism. The S.sub.N 2 area can be roughly divided into 3 regions. In part A, where the concentration of solvent is high (>65%), the HF concentration is rather low (<20%) and can still maintain an S.sub.N 2 character. In part B where the concentration of solvent is intermediate (30 to 65%) the HF concentration changes accordingly so as to give both an ionic and acidic condition. In part C, where the solvent concentration is low and the base increases >35%, the HF concentration has to change to accomodate for the solvent change. Thus, in the final analysis, the HF concentration in such system can vary from 0.1 to 60% and still be effective as the deprotecting reagent.

When trifluoroacetic acid, HF and thioanisole (pKa--7) are plotted in the diagram, the S.sub.N 2 area becomes larger than the corresponding system where dimethylsulfide (pKa--5) is used (FIG. 2). This clearly reflects that thioanisole is a weaker base than dimethylsulfide and requires a stronger HF-TFA acid system to tie up all the sulfide and cause the change from an S.sub.N 2 to an S.sub.N 1 mechanism.

In practice there are many solvent systems that can potentiate the acidity function of HF and produce the just described effects. Solvents such as formic, acetic and other C.sub.1 -C.sub.10 branched or unbranched aliphatic acids are common solvents in peptide synthesis, and can be used accordingly to substitute for trifluoroacetic acid.

A ternary system has an advantage over the HF-sulfide binary system in that it does not necessarily require a complicated HF apparatus. To achieve the effect of an S.sub.N 2 deprotection reagent, a stable HF-DMS (1:1 v/v) reagent can simply be diluted according to a three-component diagram with trifluoroacetic acid and additional sulfide, and used accordingly in plasticware. (An example of a two component system that does not require an HF apparatus is known, although it has several deficiencies and has not been used with a potentiating third component. Thus, an HF-pyridine complex (3:1, v/v) can be obtained commercially (Aldrich Chemical Co) as a stable compound, and can be diluted with TFA and sulfide to obtain a cleavage reagent within this invention.)

Solvent systems that form strong hydrogen bonds with HF will also deactivate and reduce the H.sub.o of HF. Thus the change-over point of the S.sub.N 2 to S.sub.N 1 mechanism will be shifted toward higher concentrations of HF. Solvents such as H.sub.2 O, alcohols, phenols, thiols, or thiophenols fall into this category. An example of this system is represented in FIG. 3 in which HF, H.sub.2 O and dimethylsulfide are plotted on the equilateral diagram. Since an addition of 10% of H.sub.2 O will lower the H.sub.o to -8.10, the effect of even small amounts of H.sub.2 O will be large. Accordingly the diagram in FIG. 3 shows a large area where the S.sub.N 2 mechanism predominates.

Finally, addition of certain salts can also affect the H.sub.o of HF. For example, the presence of Lewis acids such as BF.sub.3, SbF.sub.5, or TaF.sub.5 raises the H.sub.o of HF to so called "super acid" strength, i.e. H.sub.o <-11. Thus, in such mixtures as HF-BF.sub.3 -DMS or HF-BF.sub.3 -TFA-DMS the mechanism change-over will be shifted to a much lower concentration of HF. On the other hand, addition of NaF, KF of LiF will change the H.sub.o of HF to a more positive value, making it a weaker acid system. In such system of HF-KF-DMS, or HF-KF-DMS-TFA, the change over point will shift to a higher concentration of HF.

In addition to being useful for the deprotection of acid labile protecting groups of such functional groups as carboxylic or hydroxy groups, it has been discovered that the final step reagent of the present invention is also capable of deprotecting formylated tryptophan (Trp(For)) in one single manipulation. In this particular embodiment, it is preferred to add between 1 and 10% by volume of a C.sub.1 -C.sub.10 alkylthiol or arylthiol scavenger to the low HF concentration reagent, wherein aryl can be phenyl or lower alkyl- or halo substituted phenyl. Side products which are observed in high concentration HF/thiol mixtures are not found at low HF concentrations. These by-products are thiol addition side reactions to Trp(For), and occur in high concentrations of HF. Other scavengers can of course also be used, such as phenols, substituted phenols and the like, in addition to the HF/base/thiol mixture. It is believed that a low HF-base-thiol condition, where the HF concentration is maintained within the limitations described previously, is optimal. When HF concentrations are above or below these limits, deprotection of the formyl groups is either too slow or side reactions occur. If a weaker acid such as trifluoroacetic acid is substituted for HF at the same concentration, the deprotection of formyl tryptophan is found to be too slow (t 1/2 greater than 24 hours).

Another discovery made by the present inventors is that when the accompanying base in the low HF reagent in the present invention is a reductant, capable of reducing a sulfoxide group, the reagent is fully capable of reducing methionine sulfoxide to methionine. Thus, for example, when methionine sulfoxide is treated with HF and a dialkysulfide as the base, reduction is essentially quantitative.

Given these results, the reagent of the present invention can be used in one step to mildly and without side reactions deprotect most functional groups present in peptides in the final step, detach the peptide from the polymeric resin, remove formyl groups from tryptophan residues and reduce methionine sulfoxide to methionine.

The regeant can also be used in multi step deprotection procedures, wherein the first step is deprotection/detachment with the reagent of the peptide synthesis and, of course, the most commonly utilized, solid phase peptide synthesis, most especially in the automated solid phase peptide synthesis. Thus, the reagent can be provided pre-made for direct utilization in plastic vessels or in automated peptide synthesizers.

In this respect, compositions which are useful for the methodology of the present invention are also covered by the present application. These compositions encompass those comprising HF solutions plus C.sub.1 -C.sub.10 dialkyl sulfide or alkyl phenyl sulfide, especially dimethysulfide, wherein the amounts of HF and sulfide are adjusted so that when said reagent is used with any of the "indicator systems", supra, the reagent will result in the operation of an S.sub.N 2 mechanism. The compositions can be binary, ternary or higher and contain solvents, scavengers, swelling compounds, etc.

Having now generally described this invention, the same will be better understood by reference to certain specific examples, which are included herein for purposes of illustration only and are not intended to be limiting unless otherwise specified.

EXAMPLE 1

Deprotection of Ser(Bzl).

The kinetic response for the deprotection of Ser(Bzl) to changes in acidity of HF and dimethysulfide (DMS) was studied. (This is one of the so called "indicator systems", supra). The deprotection mechanism of HF-DMS mixtures can basically be accommodated by two distinct acid-rate profiles (see FIG. 4). At high HF concentration (greater than 50% of HF) the rate of removal of Ser(Bzl) increased rapidly with rising concentration of HF. The rate of deprotection of Ser(Bzl) at 50% HF concentration was found to be 1.35.times.10.sup.-3 sec.sup.-1 but increased to 3.01.times.10.sup.-3 sec.sup.-1 at 60%. The rate was too fast to be measured accurately in concentrations above 60% but was estimated to be 23.0.times.10.sup.-3 sec.sup.-1 at 75%, and 60.0.times.10.sup.-3 sec.sup.-1 at 90% HF. Thus, for practical purposes, most Ser(Bzl) residues were deprotected at 0.degree. C. in the first two minutes when exposed to the high concentration of HF used in normal deprotecting procedures. However, when the HF concentration was below 50%, the rate of change was much less dramatic and slower. With a slope of 0.13 the rate increased only 3-fold from 10% to 40% of HF concentration. For the same amount of increase of HF concentration from 60% to 90% of HF, the increase was over one 20-fold with a slope of 2. Such a sudden break in the rate-acidity profile is indicative of a change-over from an S.sub.N 2 to an S.sub.N 1 mechanism, as is shown in FIG. 4. The role of dimethylsulfide in this example serves not only as diluent but also as nucleophile. Thus, the HF-dimethylsulfide binary mixture resembles a nucleophilic acid such as HBr, which is known to remove N.alpha.- benzoxycarbonyl protecting groups by an S.sub.N 2 mechanism, rather than by an S.sub.N 1 mechanism in sulfuric acid (Homer, R. B. et al Proceedings of the Chemical Society 1963, 367).

The change-over in mechanisms of HF-dimethysulfide can also be explained by the acidity function of HF-dimethylsulfide mixtures at various concentrations. Since dimethylsulfide has a pKa of -5.3, the effective acidity function for this binary mixture should be near the pKa of dimethylsulfide so t